Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-286

It's a blind trial, so no one will know officially until the last patient has completed 24 weeks, plus a few months to compile the results. But can Big Pharma wait that long ?? Particularly if the Mortality rate is lower than would normally be expected ?

As far as being repurposed, the Safety margin for Monepantel is pretty well established already.

I think the OLE and the pre clinical results for Parkinsons and Alzhimers may have a greater impact than many realize. Also have a deep look at our Scientific Advisory Board. It really is the dream team, also why did Healey and Berry choose our P 1/2 results to present an ENCALS When they had already trialed 7 other drugs on their platform ?

Fingers crossed.